1449MO Updated Efficacy of Lenvatinib (LEN) + Pembrolizumab (PEMBRO) Vs Sunitinib (SUN) in Patients (pts) with Advanced Renal Cell Carcinoma (arcc) in the CLEAR Study
Annals of Oncology(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined